Worth reading
72In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
3618750
¥ (total issue price)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance by third-party allotment of the 22nd Stock Acquisition Rights subject to an exercise price adjustment clause
Who receives how much
Total potential shares: 24,125,000 shares (241,250 stock acquisition rights, with each right representing 100 ordinary shares)
EVO FUND (241,250 stock acquisition rights)
The lower thin line represents the existing number of shares to which these shares will be added.
¥15 per stock acquisition right
Total issue value
¥3,618,750
Amount of funds to be raised
¥2,476,464,750 (total issue price, amount payable upon exercise, and estimated net proceeds after issuance expenses; the breakdown is not specified in the body of the filing)
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥103. Adjusted daily to an amount equivalent to 100% of the closing price. Minimum exercise price: ¥52. In the event of exercise exceeding the applicable limit, an adjustment is made with the closing price on the resolution date for the issuance serving as the floor.
Exercise period
6 October 2026 to 6 October 2028
Number of Stock Acquisition Rights
Total issued: 241,250 stock acquisition rights. Number of outstanding unexercised rights: Not disclosed
Payment date
5 October 2026
Basis for determining the amount to be paid
The initial exercise price is ¥103. From the first adjustment onward, it is generally adjusted to an amount equivalent to 100% of the reference closing price. However, the minimum exercise price is ¥52. The basis for calculating the issue price is Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance by third-party allotment of the 22nd Stock Acquisition Rights subject to an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Total potential shares: 24,125,000 shares (241,250 stock acquisition rights, with each right representing 100 ordinary shares) |
| Issue price and disposal price | ¥15 per stock acquisition right |
| Total issue value | ¥3,618,750 |
| Amount of funds to be raised | ¥2,476,464,750 (total issue price, amount payable upon exercise, and estimated net proceeds after issuance expenses; the breakdown is not specified in the body of the filing) |
| Payment date | 5 October 2026 |
| Intended allottee | EVO FUND (241,250 stock acquisition rights) |
| Basis for determining the amount to be paid | The initial exercise price is ¥103. From the first adjustment onward, it is generally adjusted to an amount equivalent to 100% of the reference closing price. However, the minimum exercise price is ¥52. The basis for calculating the issue price is Not disclosed. |
| Exercise price | Initial exercise price: ¥103. Adjusted daily to an amount equivalent to 100% of the closing price. Minimum exercise price: ¥52. In the event of exercise exceeding the applicable limit, an adjustment is made with the closing price on the resolution date for the issuance serving as the floor. |
| Exercise period | 6 October 2026 to 6 October 2028 |
| Number of Stock Acquisition Rights | Total issued: 241,250 stock acquisition rights. Number of outstanding unexercised rights: Not disclosed |
Items this document does not state (17)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Payment of the total issue price for the 22nd Series of Stock Acquisition Rights issued through a private placement, as resolved on 17 September 2026, has been completed.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.